Skip to content
lifestyle.side.cr
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CancerVAX, Inc
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
August 6, 2026
CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review
July 28, 2026
CancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs
April 16, 2026
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
March 31, 2026